Literature DB >> 27035819

Immune activation caused by vascular oxidation promotes fibrosis and hypertension.

Jing Wu, Mohamed A Saleh, Annet Kirabo, Hana A Itani, Kim Ramil C Montaniel, Liang Xiao, Wei Chen, Raymond L Mernaugh, Hua Cai, Kenneth E Bernstein, Jörg J Goronzy, Cornelia M Weyand, John A Curci, Natalia R Barbaro, Heitor Moreno, Sean S Davies, L Jackson Roberts, Meena S Madhur, David G Harrison.   

Abstract

Entities:  

Year:  2016        PMID: 27035819      PMCID: PMC4811163          DOI: 10.1172/JCI87425

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Novel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative Stress.

Authors:  Hong Li; Qiang Li; Yixuan Zhang; Wenting Liu; Bo Gu; Taro Narumi; Kin Lung Siu; Ji Youn Youn; Peiqing Liu; Xia Yang; Hua Cai
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

2.  Isolevuglandins as a gauge of lipid peroxidation in human tumors.

Authors:  H P Yan; L J Roberts; S S Davies; P Pohlmann; F F Parl; S Estes; J Maeng; B Parker; R Mernaugh
Journal:  Free Radic Biol Med       Date:  2017-02-09       Impact factor: 7.376

3.  Perivascular Fibrosis Is Mediated by a KLF10-IL-9 Signaling Axis in CD4+ T Cells.

Authors:  Rulin Zhuang; Jingshu Chen; Henry S Cheng; Carmel Assa; Anurag Jamaiyar; Arvind K Pandey; Daniel Pérez-Cremades; Bofang Zhang; Aspasia Tzani; Akm Khyrul Wara; Jorge Plutzky; Victor Barrera; Preetida Bhetariya; Richard N Mitchell; Zhongmin Liu; Mark W Feinberg
Journal:  Circ Res       Date:  2022-04-20       Impact factor: 23.213

4.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14

5.  Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction.

Authors:  Njabulo Ngwenyama; Annet Kirabo; Mark Aronovitz; Francisco Velázquez; Francisco Carrillo-Salinas; Ane M Salvador; Tania Nevers; Venkataraman Amarnath; Albert Tai; Robert M Blanton; David G Harrison; Pilar Alcaide
Journal:  Circulation       Date:  2021-01-19       Impact factor: 29.690

Review 6.  Redox Switches Controlling Nitric Oxide Signaling in the Resistance Vasculature and Implications for Blood Pressure Regulation: Mid-Career Award for Research Excellence 2020.

Authors:  Atinuke Aramide Modupe Dosunmu-Ogunbi; Joseph C Galley; Shuai Yuan; Heidi M Schmidt; Katherine C Wood; Adam C Straub
Journal:  Hypertension       Date:  2021-08-23       Impact factor: 9.897

7.  Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valery Yermalitsky; Elaine L Shelton; Tadashi Otsuka; Carrie B Wiese; Linda S May-Zhang; Babak Banan; Naji Abumrad; Jiansheng Huang; Ashley B Cavnar; Annet Kirabo; Patricia G Yancey; Agnes B Fogo; Kasey C Vickers; MacRae F Linton; Sean S Davies; Valentina Kon
Journal:  Kidney Int       Date:  2021-06-05       Impact factor: 18.998

8.  Toll-Like Receptor 2 (TLR2) Knockout Abrogates Diabetic and Obese Phenotypes While Restoring Endothelial Function via Inhibition of NOX1.

Authors:  Zhen Guo; Yixuan Zhang; Chang Liu; Ji Youn Youn; Hua Cai
Journal:  Diabetes       Date:  2021-06-14       Impact factor: 9.337

9.  Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

Authors:  Tania Nevers; Ane M Salvador; Francisco Velazquez; Njabulo Ngwenyama; Francisco J Carrillo-Salinas; Mark Aronovitz; Robert M Blanton; Pilar Alcaide
Journal:  J Exp Med       Date:  2017-10-02       Impact factor: 14.307

10.  Auto-Antibody Production During Experimental Atherosclerosis in ApoE-/- Mice.

Authors:  Mark A Hutchinson; Han-Sol Park; Kimberly J Zanotti; Juan Alvarez-Gonzalez; Jing Zhang; Li Zhang; Richard Telljohann; Mingyi Wang; Edward G Lakatta; Patricia J Gearhart; Robert W Maul
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.